Ironwood Pharmaceuticals (IRWD) Free Cash Flow Growth (1y) (2011 - 2026)
Ironwood Pharmaceuticals (IRWD) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 134.35% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.21% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -37.45% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 58.76% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 97.24% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 43.69% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 35.56% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 679.81 Mn | 600.69 Mn | - | 486.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 486.70% |
| Mar 31, 2026 | -74.30% |
| Dec 31, 2025 | 390.18% |
| Sep 30, 2025 | 382.13% |
| Jun 30, 2025 | -145.11% |
| Mar 31, 2025 | -55.64% |
| Dec 31, 2024 | -57.29% |
| Sep 30, 2024 | -69.55% |
| Jun 30, 2024 | -4.45% |
| Mar 31, 2024 | -43.96% |
| Dec 31, 2023 | -55.03% |
| Sep 30, 2023 | -53.05% |
| Jun 30, 2023 | -42.94% |
| Mar 31, 2023 | 25.02% |
| Dec 31, 2022 | 22.92% |
| Sep 30, 2022 | -8.05% |
| Jun 30, 2022 | 26.17% |
| Mar 31, 2022 | -13.00% |
| Dec 31, 2021 | 25.16% |
| Sep 30, 2021 | 39.96% |